Internal emails show how RFK Jr.’s team sought to sway the CDC
Internal Emails Reveal RFK Jr.'s Influence on CDC's Vaccine Policies
Internal emails show how RFK Jr s - Recent disclosures of internal communications have provided insight into how the Centers for Disease Control and Prevention (CDC) handled contentious public health decisions during President Trump's second term. These documents, released by the Senate Committee on Health, Education, Labor, and Pensions, highlight the pressure exerted by Robert F. Kennedy Jr.—then Secretary of Health and Human Services—and his team on the agency. The emails span several months and detail interactions between CDC officials and HHS representatives, revealing moments of tension and strategic maneuvering.
A Flurry of Political Interference
Among the key events highlighted in the emails is the administration’s early attempt to halt a flu vaccine advertising campaign. In mid-February 2025, during a peak flu season, CDC communications official Nicole Coffin relayed instructions from HHS communications chief Andrew Nixon. According to her email, Nixon had asked the CDC to remove all ads promoting flu shots, emphasizing a focus on "informed consent" messaging. Coffin noted that the directive "came directly from the Secretary," underscoring RFK Jr.'s central role in shaping the CDC’s approach.
“Prioritized politics over public health, ignored expert guidance, and endangered people, particularly children.”
Senator Bernie Sanders, the committee’s independent ranking member, used these emails to argue that RFK Jr. and his allies had undermined scientific consensus. The senator’s remarks, cited in the release, underscore the perception that political agendas were prioritized over evidence-based decisions during the Trump administration.
Reorganizing the CDC’s Advisory Panel
Another focal point of the emails is the replacement of the CDC’s Advisory Committee for Immunization Practices (ACIP). This panel, responsible for recommending vaccines, was entirely removed by RFK Jr. in the months following his appointment. A memo from a Kennedy aide revealed that the decision was partly driven by the desire to control the committee’s direction, with the goal of "depoliticizing" it by appointing members aligned with his views.
The memo suggested that Kennedy’s team had been frustrated by the Biden administration’s last-minute appointments to fill ACIP vacancies. "They think last minute appointments were a way to block," a CDC official wrote in notes from an internal meeting, "didn’t ask us for help." The email chain also highlighted Kennedy’s eagerness to replace members, stating he had "a bench of 10 ready to replace" and seemed indifferent to their specific qualifications.
Impact on Federal Vaccine Policies
The ACIP’s recommendations carry significant weight, as they directly influence federal guidelines and insurance coverage. By reshaping the panel, RFK Jr. aimed to reshape the narrative around vaccines, including those for influenza. His picks included individuals with histories of questioning vaccine safety or criticizing public health protocols. Some had ties to legal actions against vaccine manufacturers, while others had personal investments in vaccine development.
One Kennedy adviser, Stuart Burns, was tasked with drafting a memo outlining the plan to restructure the committee. The document stated that the objective was to "re-establish public confidence in vaccine science" through a "clean sweep" of existing members. This move was seen as an effort to align the CDC’s messaging with RFK Jr.’s skepticism of vaccines, particularly those recommended by the previous administration.
Reactions and Legal Challenges
The CDC’s internal emails also show the consequences of these decisions. A federal judge ruled in March that the changes to the ACIP were unlawful, citing the Trump administration’s failure to follow proper procedures. The judge’s decision emphasized that the administration had "disregarded" required protocols when removing the panel members, suggesting a lack of due process in the process.
Despite the legal scrutiny, the emails reveal a pattern of RFK Jr.’s team asserting control over the CDC’s operations. For example, when Coffin sought to share details about the agency’s flu shot campaigns with Nixon, the HHS official confirmed that the request was "a direct ask from Secretary Kennedy." This exchange highlights the coordinated effort to adjust messaging and align it with political priorities.
Disputes Over Expert Guidance
CDC officials expressed concerns about the potential risks of halting the flu vaccine campaign. One email warned that stopping a program in the middle of a severe flu season could damage the agency’s reputation and lead to legal complications. The official noted that the CDC’s existing contracts and funding agreements were "likely" affected by the decision to pause pro-vaccination ads.
While the "Wild to Mild" campaign was immediately paused, the "Get My Flu Shot" initiative remained active. This inconsistency in the CDC’s response to the directives has fueled debates about the balance between scientific advice and political influence. The emails suggest that RFK Jr.’s team selectively applied pressure, targeting specific campaigns while leaving others untouched.
Legacy of the CDC’s Leadership Changes
The removal of ACIP members marked a pivotal moment in the CDC’s leadership under RFK Jr. The emails indicate that the process was not just about replacing individuals but about reorienting the agency’s mission. Kennedy’s stated goal of "depoliticizing" the committee reflects a broader strategy to align the CDC with his personal views on vaccine safety and efficacy.
Monarez, the CDC’s director at the time, was ousted in August 2025, leading to the resignation of Debra Houry, the former chief medical officer. The Senate committee released the emails as part of its investigation, framing them as evidence of RFK Jr.’s team’s efforts to sway the CDC’s decisions. The timing of the release—just weeks after Monarez’s removal—suggests a deliberate effort to highlight the extent of political influence on the agency.
Broader Implications for Public Health
The emails have sparked discussions about the role of political leaders in shaping public health policies. Critics argue that the CDC’s independence was compromised by RFK Jr.’s directives, which prioritized messaging over data. For instance, the emphasis on "informed consent" over proactive vaccination campaigns has raised questions about how public health messaging is curated during periods of high demand.
Meanwhile, supporters of RFK Jr. contend that the changes were necessary to address perceived flaws in the previous administration’s approach. They point to the "clean sweep" of ACIP members as a way to restore public trust in vaccine science, especially after years of controversy. However, the emails suggest that this effort was accompanied by a lack of consultation with CDC experts, further intensifying the debate over the agency’s autonomy.
Continued Scrutiny and Future Challenges
As the Senate committee continues its investigation, the emails serve as a critical resource for understanding the dynamics between the CDC and the HHS. The release of these documents has also prompted CBS News to seek comments from HHS officials, indicating ongoing interest in the administration’s handling of vaccine-related decisions.
The situation raises broader concerns about the intersection of politics and science in public health. With the ACIP’s recommendations now under new leadership, the implications for federal vaccine policies and public trust remain under close examination. The emails provide a detailed account of how RFK Jr.’s team sought to reshape the CDC’s role, leaving a legacy of influence that will likely be scrutinized for years to come.
These internal communications not only document the strategies employed by RFK Jr. and his allies but also reveal the internal conflicts within the CDC. By highlighting the tension between scientific expertise and political directives, the emails offer a window into the challenges faced by public health agencies during high-stakes decision-making. The continued debate over these actions underscores the importance of transparency in shaping policies that affect millions of lives.